239 related articles for article (PubMed ID: 18160433)
1. NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis.
Walsh KB; Lanier LL; Lane TE
J Virol; 2008 Mar; 82(6):3031-44. PubMed ID: 18160433
[TBL] [Abstract][Full Text] [Related]
2. Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.
Weinger JG; Plaisted WC; Maciejewski SM; Lanier LL; Walsh CM; Lane TE
Stem Cells; 2014 Oct; 32(10):2690-701. PubMed ID: 24898518
[TBL] [Abstract][Full Text] [Related]
3. Perforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells.
Bergmann CC; Parra B; Hinton DR; Ramakrishna C; Dowdell KC; Stohlman SA
J Virol; 2004 Feb; 78(4):1739-50. PubMed ID: 14747539
[TBL] [Abstract][Full Text] [Related]
4. Evidence for differential roles for NKG2D receptor signaling in innate host defense against coronavirus-induced neurological and liver disease.
Walsh KB; Lodoen MB; Edwards RA; Lanier LL; Lane TE
J Virol; 2008 Mar; 82(6):3021-30. PubMed ID: 18094157
[TBL] [Abstract][Full Text] [Related]
5. FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.
Blanc CA; Rosen H; Lane TE
J Neuroinflammation; 2014 Aug; 11():138. PubMed ID: 25138356
[TBL] [Abstract][Full Text] [Related]
6. Important roles for gamma interferon and NKG2D in gammadelta T-cell-induced demyelination in T-cell receptor beta-deficient mice infected with a coronavirus.
Dandekar AA; O'Malley K; Perlman S
J Virol; 2005 Aug; 79(15):9388-96. PubMed ID: 16014902
[TBL] [Abstract][Full Text] [Related]
7. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40.
Pinto AK; Jamieson AM; Raulet DH; Hill AB
J Virol; 2007 Nov; 81(22):12564-71. PubMed ID: 17855532
[TBL] [Abstract][Full Text] [Related]
8. CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus.
Stohlman SA; Hinton DR; Parra B; Atkinson R; Bergmann CC
J Virol; 2008 Mar; 82(5):2130-9. PubMed ID: 18094171
[TBL] [Abstract][Full Text] [Related]
9. T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner.
Teng MW; Kershaw MH; Hayakawa Y; Cerutti L; Jane SM; Darcy PK; Smyth MJ
J Biol Chem; 2005 Nov; 280(46):38235-41. PubMed ID: 16169855
[TBL] [Abstract][Full Text] [Related]
10. Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system.
Bergmann CC; Altman JD; Hinton D; Stohlman SA
J Immunol; 1999 Sep; 163(6):3379-87. PubMed ID: 10477608
[TBL] [Abstract][Full Text] [Related]
11. Perforin-mediated effector function within the central nervous system requires IFN-gamma-mediated MHC up-regulation.
Bergmann CC; Parra B; Hinton DR; Chandran R; Morrison M; Stohlman SA
J Immunol; 2003 Mar; 170(6):3204-13. PubMed ID: 12626579
[TBL] [Abstract][Full Text] [Related]
12. NKG2D stimulation of CD8
Kavazović I; Lenartić M; Jelenčić V; Jurković S; Lemmermann NAW; Jonjić S; Polić B; Wensveen FM
Eur J Immunol; 2017 Jul; 47(7):1123-1135. PubMed ID: 28378389
[TBL] [Abstract][Full Text] [Related]
13. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
[TBL] [Abstract][Full Text] [Related]
14. NKG2D signaling and host defense after mouse hepatitis virus infection of the central nervous system.
Walsh KB; Lodoen MB; Lanier LL; Lane TE
Adv Exp Med Biol; 2006; 581():369-72. PubMed ID: 17037561
[No Abstract] [Full Text] [Related]
15. The role of the NKG2D immunoreceptor in immune cell activation and natural killing.
Jamieson AM; Diefenbach A; McMahon CW; Xiong N; Carlyle JR; Raulet DH
Immunity; 2002 Jul; 17(1):19-29. PubMed ID: 12150888
[TBL] [Abstract][Full Text] [Related]
16. Characterization of T cells expanded in vivo during primary mouse hepatitis virus infection in mice.
Kyuwa S; Machii K; Okumura A; Toyoda Y
J Vet Med Sci; 1996 May; 58(5):431-7. PubMed ID: 8741603
[TBL] [Abstract][Full Text] [Related]
17. Immunological changes in different patient populations with chronic hepatitis C virus infection.
Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
[TBL] [Abstract][Full Text] [Related]
18. Contributions of CD8+ T cells and viral spread to demyelinating disease.
Marten NW; Stohlman SA; Atkinson RD; Hinton DR; Fleming JO; Bergmann CC
J Immunol; 2000 Apr; 164(8):4080-8. PubMed ID: 10754301
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease.
Dickey LL; Worne CL; Glover JL; Lane TE; O'Connell RM
J Neuroinflammation; 2016 Sep; 13(1):240. PubMed ID: 27604627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
